Full-Time

Director – Laboratory and Facilities Operations

Confirmed live in the last 24 hours

Scribe Therapeutics

Scribe Therapeutics

51-200 employees

Develops CRISPR-based genetic medicine solutions

Biotechnology
Healthcare

Compensation Overview

$200k - $230kAnnually

+ Incentives

Senior, Expert

Alameda, CA, USA

Category
Lab & Research
Life Sciences
Medical Research
Required Skills
NetSuite
Supply Chain Management
Inventory Management
PowerPoint/Keynote/Slides
Requirements
  • Proven track record managing research facilities in Biotechnology or Pharmaceutical industries
  • 12+ years experience in supply chain and lab management
  • Associate or Bachelor’s degree, or equivalent
  • Experience implementing and managing Company wide OSHA, EH&S and other environmental compliance programs
  • In-depth experience with the set-up/design, operation and maintenance of facilities and equipment in a Biotechnology industry setting
  • Experience overseeing the receiving of lab equipment, chemicals, biologics, and temperature sensitive samples and reagents
  • Equipment management experience with maintenance, calibration, and validation of analytical and process equipment
  • Exceptional organization and prioritization skills
  • Proficiency in microsoft office, particularly developing powerpoint slides and excel budgets to articulate project spending and progress.
  • Experience with Netsuite or similar ERP system
  • Ability to work both independently and collaboratively in a fast-paced, interdisciplinary research team
Responsibilities
  • Provide strategic direction, technical supervision and support to the Lab and Facilities Operations team who manages daily operations. Provides regular performance reviews and sets team’s objectives aligned with Scribe’s annual goals and individual development plans.
  • Drive improvements in service, efficiency, and cost reduction through standardization of common practices across the company, Track performance across the 3 areas (service, efficiency, cost reduction).
  • Establish and own a business continuity plan including extended-hours coverage and response plan.
  • Establish processes and maintain an infrastructure to enable laboratory operations across the organization including: capital plan/expenditures (from forecasting needs to installation), lab equipment and instrumentation (i.e., contracts, maintenance, repair, calibration, upgrade and retiring), lab consumables (i.e., contracts, procurement, order management, inventory management), lab safety (i.e., chemical storage, waste, build system for MSDS information, EH&S oversight, and OSHA oversight).
  • Effectively collaborate with members within a fully integrated team to facilitate execution on projects within established timelines
  • Foster a driven, fast-paced, dynamic, and fun environment in which to do rigorous science
  • Provide strategic direction, and supervision to the Facilities Operations team who manages day-to-day operations. Provides regular performance reviews and sets team’s objectives aligned with Scribe’s annual goals and individual development plans.
  • Actively ensure company compliance with all Federal, State and local permits, licenses, and safety regulations
  • Oversight of capital projects where applicable, facilitate communication between all internal and external stakeholders including architects, lab designers and contractors on lab and building renovations and improvements, ensuring projects are completed timely and on budget.
  • Participate in site capacity expansion planning as necessary. Provide design review for facilities/utilities system, layout, personnel flow, and HVAC
  • Supervise facilities vendor management and performance against budget in collaboration with finance function

Scribe Therapeutics focuses on genetic medicine by utilizing CRISPR technology to develop solutions for genetic diseases. CRISPR acts like molecular scissors, allowing for precise editing of DNA sequences to potentially correct genetic defects. The company collaborates with healthcare providers, research institutions, and pharmaceutical companies, generating revenue through partnerships and licensing its technology. Scribe Therapeutics is also working on advanced delivery methods for in vivo applications, enabling targeted gene therapy that can address specific genetic variants. Unlike many competitors, Scribe emphasizes exceptional specificity in its gene-editing approach, aiming to provide precise treatments for genetic disorders. The ultimate goal is to advance the field of genetic medicine and improve patient outcomes through effective gene therapies.

Company Stage

N/A

Total Funding

$136.2M

Headquarters

Alameda, California

Founded

2017

Growth & Insights
Headcount

6 month growth

11%

1 year growth

17%

2 year growth

81%
Simplify Jobs

Simplify's Take

What believers are saying

  • Scribe's innovative XE and ELXR platforms have demonstrated high efficacy and safety in non-human primate studies, indicating strong potential for human applications.
  • The company's partnerships with industry giants like Sanofi and Eli Lilly provide significant financial backing and collaborative opportunities, enhancing its growth prospects.
  • Scribe's recent appointments of experienced leaders in R&D and discovery biology strengthen its scientific and operational capabilities.

What critics are saying

  • The highly competitive genetic medicine market requires continuous innovation to maintain a leading position.
  • Dependence on partnerships for revenue generation could pose risks if collaborations do not yield expected outcomes.

What makes Scribe Therapeutics unique

  • Scribe Therapeutics leverages its proprietary CRISPR X-Editor (XE) and Epigenetic Long-Term X-Repressor (ELXR) technologies, which offer superior potency and specificity compared to traditional CRISPR-Cas9 systems.
  • The company's focus on in vivo genetic medicine and allele-specific targeting sets it apart in the genetic medicine market, enabling precise therapeutic interventions.
  • Scribe's strategic partnerships with major pharmaceutical companies like Sanofi and Eli Lilly's Prevail Therapeutics highlight its credibility and potential for large-scale impact.

Help us improve and share your feedback! Did you find this helpful?